Early Stage Venture Sensei Biotherapeutics Raises Series A of $28500000

October 6, 2020

About Sensei Biotherapeutics

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

Website: Learn more on Sensei Biotherapeutics’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Sensei Biotherapeutics

Amount Raised28500000 USD
Announced Date2020-10-07
Equity Only FundingYes
Organization LocationGaithersburg, Maryland, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsCambrian Biopharma, H&S Ventures
Number of Investors5
Number of Partner Investors1